Is low-grade prostatic intraepithelial neoplasia a risk factor for cancer?

Prostate Cancer and Prostatic Diseases

Volumn 6, Issue 4, 2003, Pages 305-310

  Goeman, L ^a   Joniau, Steven ^a   Ponette, D ^a   Van der Aa, F ^a   Roskams, T ^a   Oyen, R ^a   Van Poppel, H ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Adenocarcinoma; Chemoprevention; Prostatic intraepithelial neoplasia

Indexed keywords

ALPHA TOCOPHEROL; PROSTATE SPECIFIC ANTIGEN; SELENIUM;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RISK; CANCER STAGING; CHEMOPROPHYLAXIS; CONTROLLED STUDY; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; RISK FACTOR; VITAMIN SUPPLEMENTATION;

AGED; BIOPSY, NEEDLE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RISK FACTORS; SELENIUM; VITAMIN E;

EID: 0347268970     PISSN: 13657852     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500681     Document Type: Article

References (46)

1. Bostwick DG. Prostatic intraepithelial neoplasia is a risk factor for cancer. Semin Urol Oncol 1999; 17: 187-198.
2. Kamat AM, Lamm DL. Chemoprevention of urological cancer. J Urol 1999; 161: 1748-1760.
3. Bostwick DG, Neumann R, Qian J, Cheng L. Reversibility of prostatic intraepithelial neoplasia: implications for chemoprevention. Eur Urol 1999; 35: 492-495.
4. Sakr WA. Prostatic intraepithelial neoplasia: a marker for high-risk groups and a potential target for chemoprevention. Eur Urol 1999; 35: 474-478.
5. Vis AN, Van der Kwast TH. Prostatic intraepithelial neoplasia and putative precursor lesions of prostate cancer: a clinical perspective. BJU Int 2001; 88: 147-157.
6. Lipski B, Garcia R, Brawer M. Prostatic intraepithelial neoplasia: significance and management. Semin Urol Oncol 1996; 14: 149-155.
7. Mc Neal JE, Bostwick DG. Intraductal dysplasia: a premalignant lesion of the prostate. Hum Pathol 1986; 17: 64-71.
8. Zlotta A, Schulman C. Clinical evolution of prostatic intraepithelial neoplasia. Eur Urol 1999; 35: 498-503.
9. Swinnen JV et al. Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer. Int J Cancer 2002; 98: 19-22.
10. Coogan C, Bostwick D, Bloom K, Gould V. Glycoprotein A-80 in the human prostate: immunolocalization in prostatic intrepithelial neoplasia, carcinoma, radiation failure, and after neoadjuvant hormonal therapy. Urology 2003; 61: 248-252.
11. Epstein JE, Potter SR. The pathological interpretation and significance of prostate needle biopsy findings: implications and current controversies. J Urol 2001; 166: 402-410.
12. Langer JE, Rovner ES, Coleman BG. Strategy for repeat biopsy of patients with prostatic with prostatic intraepithelial neoplasia detected by prostate needle biopsies. J Urol 1996; 154: 1791-1794.
13. Shepherd D et al. Repeat biopsy strategy in men with isolated prostatic intraepithelial neoplasia on prostate needle biopsy. J Urol 1996; 156: 460-463.
14. Kamoi K, Troncoso P, Babaian J. Strategy for repeat biopsy in patients with high grade prostatic intraepithelial neoplasia. J Urol 2000; 163: 819-823.
15. Montironi R, Mazzucchelli R, Scarpelli M. Precancerous lesions and conditions of the prostate. Ann NY Acad Sci 2002; 963: 169-184.
16. Boyle W, Maisonneuve P, Napalkov P. Geographical and temporal patterns of incidence and mortality from prostate cancer. Urology 1995; 46(Suppl 3A): 47-55.
17. Parker S, Tong T, Bolden S, Wingo P. Cancer statistics. Ca Cancer J Clin 1997; 47: 5-27.
18. Parkin D, Muir C. Cancer incidence in five continents: comparability and quality data. IARC Sci Publ 1992; 120: 45-173.
19. Muir C, Nectoux J, Staszewski J. The epidemiology of prostatic cancer: geographical distribution and time-trends. Acta Oncol 1991; 30: 133-140.
20. Stellman S, Wang Q. Cancer mortality in Chinese migrants to New York City; comparison with Chines in Tianjin and with United States born whites. Cancer 1994; 73: 1270-1275.
21. Shimizu H et al. Cancers of the prostate and the breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 1991; 63: 963-966.
22. Sakr W et al. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol 1993; 150: 379-385.
23. Dhom G. Epidemic logic aspects of latent and clinically manifest carcinoma of the prostate. J Cancer Res din Oncol 1983; 106: 210-218.
24. Breslow N, Chan C, Dhom G. Latent carcinoma of the prostate at autopsy in seven areas. Int J Cancer 1997; 20: 680-688.
25. Yatani R, Chigusa I, Akazaki K. Geographic pathology of latent prostatic carcinoma. Int J Cancer 1982; 9: 611-616.
26. Hebert J et al. Nutritional and socio-economic factors in relation to prostate cancer mortality : a cross-national study. J Natl Cancer Inst 1998; 90: 1637-1647.
27. Chow C. Nutritional influence on cellular antioxidant defense systems. Am J Clin Nutr 1979; 32: 1066-1081.
28. Schrauzer G, White D, Schneider C. Cancer mortality correlation studies. Statistical associations with dietary selenium intakes. Bionorg Chem 1977; 7: 23-24.
29. Hunter D, Moris J, Stampfer M. A prospective study of selenium status and breast cancer risk. JAMA 1990; 264: 1128-1131.
30. Yoshiwaza K, Willett W, Morris S. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 1998; 90: 1219-1224.
31. Clark L, Combs C, Turnbull B. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin; a randomised controlled trial. JAMA 1996; 276: 1957-1963.
32. Clark L, Dalkin B, Kronegrad A. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol 1998; 81: 730-734.
33. Wang Y, Heston W, Corr J. Decreased growth of established human prostate LNCaP tumours in nude mice fed a low fat diet. J Natl Cancer Inst 1995; 87: 1427-1432.
34. Fleshner N, Fair W, Huryk R. Vitamin E inhibits the high fat diet promoted growth of established human prostate LNCaP tumours in nude mice. J Urol 1999; 161: 1651-1654.
35. Chan J, Stampfer M, Ma J. Supplemental vitamin E and prostate cancer risk in a large cohort of men in the United States. Cancer Epidemiol Biomarkers Prev 1999; 8: 893-899.
36. Heinonen O, Albanes D, Virtamo J. Prostate cancer and supplementation with alfa-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 1998; 90: 440-446.
37. Kamat A, Lamm D. Chemoprevention of urological cancer. J Urol 1999; 161: 1748-1760.
38. Schulman C et al. Prevention of prostate cancer. Scand J Urol Nephrol Suppl 2000; 205: 50-61.
39. Aboseif S, Shonohara K, Weidner N. The significance of prostatic intraepithelial neoplasia. Br J Urol 1995; 76: 355-359.
40. Berner A, Danielsen HE, Pettersen EO. DNA distribution in the prostate : normal gland, benign and premalignant lesions and subsequent adenocarcinomas. Anal Quant Cytol Histol 1993; 15: 247-252.
41. Davidson D, Bostwick DG, Qian J. Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma. Predictive accuracy in needle biopsies. J Urol 1995; 154: 1295-1299.
42. Krishnamurthi V, Klein EA, Levin HS. Probability of prostate cancer detection following diagnosis of prostatic intraepithelial neoplasia (PIN). J Urol 1999; 157(Suppl): 366.
43. Markham CW. Prostatic intraepithelial neoplasia: detection and correlation with invasive cancer in fine-needle biopsy. Urology 1989; 24(Suppl): 57-61.
44. Perachino M, Diciolo L, Barbetti V. Results of rebiopsy for suspected prostate cancer in symptomatic men with elevated PSA levels. Eur Urol 1997; 32: 155-159.
45. Raviv G, Zlotta AR, Jansen TH. Does prostate specific antigen and prostate-specific antigen density enhance the detection of prostate cancer in patients initially diagnosed to have prostatic intraepithelial neoplasia? Cancer 1996; 77: 2103-2108.
46. Rovner E, Schanne E, Malkowicz S. Transurethral biopsy of the prostate for persistently elevated or increasing prostate specific antigen following multiple negative transrectal biopsies. J Urol 1997; 158: 138-141.